In addition, Zhuang et al. reported that FAT4 mutations significantly down-regulated their RNA expression levels and were remarkably enriched in early-stage (I/II) colorectal cancer patients, portending a low recurrence rate and longer PFS [38]. This evidence concerns the gene FAT4 and colorectal cancer.